Stocksigma LogoStocksigma Logo

Sai Parenterals to Acquire Majority Stake in Bion Therapeutics

Sai Parenterals approved acquiring a majority stake in Hyderabad-based Bion Therapeutics India via its wholly owned subsidiary, SP Analytics, in an

Sai Parenterals to Acquire Majority Stake in Bion Therapeutics

Sai Parenterals Ltd · Others (Uncategorized) · 17 Nov 2026, 2:35 am

Sai Parenterals to Acquire Majority Stake in Bion Therapeutics Sai Parenterals approved acquiring a majority stake in Hyderabad-based Bion Therapeutics India via its wholly owned subsidiary, SP Analytics, in an all-cash deal expected to close by 30th Nov'26. The transaction will be funded through IPO proceeds earmarked for general corporate purposes and debt. Bion Therapeutics, a branded formulations prescription business, reported total income of ₹47.14 Cr in FY25, ₹47.29 Cr in FY26, and ₹28.75 Cr for H1FY27 ended 30th Sep'26. Valuation will be determined by an independent valuer.

Original exchange filing (PDF)

More announcements from Sai Parenterals Ltd

All Sai Parenterals Ltd announcements